期刊文献+

宫颈癌免疫功能与临床分期相关性研究 被引量:6

下载PDF
导出
摘要 目的探讨宫颈癌患者细胞免疫功能与临床分期的相关性。方法选取95例宫颈癌患者(宫颈癌组)和95例正常健康体检妇女(健康组)为研究对象,检测两组受检者外周血T细胞亚群(CD3+、CD3+CD4+、CD3+CD8+)及NK细胞(CD16++CD56+)数量情况,观察两组及不同分期宫颈癌患者中上述细胞数量情况变化情况。结果宫颈癌组外周血T细胞亚群及NK细胞数量情况与健康组比较差异有统计学意义(P<0.05);外周血CD3+、CD3+CD4+及CD16++CD56+细胞数量与宫颈癌临床病理分期呈负相关性(P<0.05);外周血CD3+CD8+细胞数量与宫颈癌临床病理分期呈正相关性(P<0.05)。结论宫颈癌患者免疫功与临床病理分期呈负相关。
出处 《江西医药》 CAS 2014年第3期238-240,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献8

二级参考文献51

  • 1展富琴,冯萍.恶性肿瘤患者化疗前后免疫功能的变化[J].中国血液流变学杂志,2007,17(1):137-138. 被引量:17
  • 2Tan W,Zhang W,Strasner A et al.Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK sig-nalling(J).Nature,2011,470(7335):548.
  • 3Liu H,Xu L,Wei JE et al.Role of CD4+CD25+regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro(J).Anat Rec(Hoboken),2011,294(5):781.
  • 4van Diest PJ,Vleugel MM,van der Wall E.Expression of HIF-1 alpha in human tumours.J Clin Pathol,2005,58(3):335.
  • 5Schumacker PT.Hypoxia-inducible factor-1 (HIF-1).Crit Care Med ,2005,33(12 Suppl) :$423.
  • 6Krishnamachary,B,Berg--Dixon S,Kelly B,et al. Regulation of colon carcinoma cell invasion by hypoxia--inducible factor 1. Cancer Res,2003,63(5) : 1138.
  • 7Mayer A, Hockel M, Vaupel P.Endogenous hypoxia markers in lo- cally advanced cancers of the uterine cervix:realty or wishful thinking.Strahlenther Onkol, 2006,182(9) : 501.
  • 8Shi YH,Wang Y X,Bingle L.et al.In vitro study of HIF-1 activa- tion and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions:involvement of P1-3K/AKT and MEK1/EPK pathways. J Patho 1,2005,205(4) : 530.
  • 9Miner E,Michel G,Mottet D,et al.Transduction pathways involved in hypoxia-- inducible factor-1 phosphorhlation and activation. Free Radic Biot,2001,31(7) : 847.
  • 10Clottes E.Hypoxia--inducible factor--l:regulation.Involvement in carcinogenesis an d target for an ticancer therapy. Bull Cancer, 2005,92(2): 119.

共引文献102

同被引文献45

  • 1王倩,孙树三.宫颈癌患者外周血Th_1/Th_2细胞因子表达水平的研究[J].肿瘤防治杂志,2004,11(7):706-707. 被引量:7
  • 2武燕.宫颈癌患者Th1/Th2细胞因子表达水平的研究[J].肿瘤研究与临床,2006,18(5):310-312. 被引量:24
  • 3李锋,熊丽丽,田晓予,米建强.高危型HPV感染的宫颈癌和癌前病变中Th1/Th2漂移情况研究[J].河南科技大学学报(医学版),2007,25(2):88-89. 被引量:7
  • 4Qinfeng S,Depu W,Xiaofeng Y,et al.In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue[J].Radiat Res,2013,179(5):584-589.
  • 5Gening TP,Antoneeva II,Abakumova TV,et al.Dynamics of proinflammatory cytokine levels and their role in the development of local and systemic effects during progressing cervical cancer[J].Bull Exp Biol Med,2014,157(6):776-780.
  • 6Paradkar PH, Joshi JV, Mertia PN, et al. Role of cytokines in genesis, progression and prognosis of cervical cancer [J]. Asian Pac J Can- cer Prey, 2014, 15(9): 3851-3864.
  • 7Sharma A, Rajappa M, Satyam A, et al. Cytokines (TH1 and TH2) in pa- tients with advanced cervical cancer undergoing neoadjuvant chemora- diation: correlation with treatment response [J]. Int J Gynecol Cancer, 2009, 19(7): 1269-1275.
  • 8Siegel R, Naishadham D, Jemal A. Cancer statistics [ J ]. CA Cancer J Clin,2012,62 ( 1 ) : 10-29.
  • 9Pan L,Cheng J, Zhou M, et al. The SUVmax ( maximum stand- ardized uptake value for F - 18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC -ag) function as prog- nostic biomarkers in patients with primary cervical cancer[ J]. J Cancer Res Clin 0ncol,2012,138(2) :239-246.
  • 10Varro R, Chen R, Sepulveda H, et al. Bead - based multianalyte flow immunoassays : the cytometric bead array system [ J ]. Meth- ods Mol Bio1,2007,378 : 125-152.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部